AbbVie Inc. (TSX:ABBV)
Canada · Delayed Price · Currency is CAD 40.81
+0.57 (1.42%)
Oct 30, 2026, 3:50 PM EDT
AbbVie Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 66,014 | 61,160 | 56,334 | 54,318 | 58,054 | 56,197 |
Revenue Growth | 10.68% | 8.57% | 3.71% | -6.44% | 3.30% | 22.69% |
Gross Profit Gross Profit Growth | 48,665 | 43,803 | 39,645 | 37,492 | 41,527 | 38,883 |
Operating Income Operating Income Growth | 24,072 | 21,115 | 17,422 | 18,214 | 20,228 | 19,759 |
Net Income Net Income Growth | 10,302 | 4,186 | 4,238 | 4,820 | 11,782 | 11,468 |
Earnings Per Share EPS Growth | 5.81 | 2.36 | 2.39 | 2.72 | 6.63 | 6.45 |
EPS Growth | 339.80% | -1.26% | -12.13% | -58.97% | 2.79% | 137.13% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Immunology Immunology Growth | 33,867 | 30,406 | 26,682 | 26,136 | 28,924 | 25,284 |
Neuroscience Neuroscience Growth | 12,453 | 10,767 | 8,999 | 7,717 | 6,528 | 5,927 |
Oncology Oncology Growth | 6,641 | 6,655 | 6,555 | 5,915 | 6,577 | 7,228 |
Aesthetics Aesthetics Growth | 4,930 | 4,860 | 5,176 | 5,294 | 5,333 | 5,233 |
Eye Care Eye Care Growth | - | 2,109 | 2,242 | 2,415 | 2,701 | 3,567 |
Other Key Products Other Key Products Growth | 3,779 | 3,736 | 3,648 | 3,806 | 3,854 | 5,489 |
All Other All Other Growth | 3,764 | 2,627 | 3,032 | 3,035 | 4,137 | 2,673 |
Revenue (Total) Revenue (Total) Growth | 66,014 | 61,160 | 56,334 | 54,318 | 58,054 | 56,197 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 6,569 | 5,257 | 5,555 | 12,816 | 9,229 | 9,830 |
Total Debt Total Debt Growth | 70,885 | 68,400 | 68,250 | 60,579 | 64,583 | 77,597 |
Net Cash (Debt) Net Cash Growth | -64,316 | -63,143 | -62,695 | -47,763 | -55,354 | -67,767 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -36.28 | -35.61 | -35.36 | -26.94 | -31.13 | -38.14 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 19,030 | 18,806 | 22,839 | 24,943 | 22,777 |
Capital Expenditures CapEx Growth | - | -1,214 | -974 | -777 | -695 | -787 |
Free Cash Flow Free Cash Flow Growth | - | 17,816 | 17,832 | 22,062 | 24,248 | 21,990 |
Free Cash Flow Growth | - | -0.09% | -19.17% | -9.01% | 10.27% | 30.97% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 73.72% | 71.62% | 70.38% | 69.02% | 71.53% | 69.19% |
Operating Margin | 36.46% | 34.52% | 30.93% | 33.53% | 34.84% | 35.16% |
Pretax Margin | 19.41% | 10.79% | 6.60% | 11.51% | 23.21% | 23.11% |
Profit Margin | 15.61% | 6.84% | 7.52% | 8.87% | 20.29% | 20.41% |
FCF Margin | - | 29.13% | 31.65% | 40.62% | 41.77% | 39.13% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.200 | 6.650 | 6.290 | 5.990 | 5.710 | 5.310 |
Dividend Per Share Growth | 28.19% | 5.72% | 5.01% | 4.90% | 7.53% | 9.71% |
Dividend Yield | 2.94% | 2.91% | 3.54% | 3.87% | 3.54% | 3.92% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 50.77 | 96.47 | 74.10 | 56.77 | 24.25 | 20.87 |
P/FCF Ratio | 28.57 | 22.67 | 17.61 | 12.40 | 11.78 | 10.89 |
PS Ratio | 7.76 | 6.60 | 5.57 | 5.04 | 4.92 | 4.26 |